Insulin Receptors, Receptor Antibodies, and the Mechanism of Insulin Action
C. Ronald Kahn(Joslin Diabetes Center), Emmanuel Van Obberghen(Centre National de la Recherche Scientifique), Carl Grünfeld(University of California, San Francisco), Kathleen L. Baird(National Institutes of Health), U. Lang(National Institutes of Health), Fredrik Karlsson(National Institutes of Health), Len C. Harrison(The Royal Melbourne Hospital), Masato Kasuga(The Institute of Medical Science, Asahi Life Foundation), Judith M. Podskalny(National Institutes of Health), George L. King(Joslin Diabetes Center), JEFFERY S. FLIER(National Institutes of Health), J T Harmon(National Institutes of Health)
Cited by 168
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Insulin Receptor Signaling in Normal and Insulin-Resistant States
|Cold Spring Harbor Perspectives in Biology|2014|1.4k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k